Biomarkers of Acute Stroke in Clinic

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Ischemic StrokeIschemiaAtrial FibrillationTransient Ischemic AttackTransient Cerebrovascular EventsThrombotic StrokeStrokeStroke, AcuteStroke, IschemicStroke, ComplicationStroke of Basilar ArteryAtherosclerosisAtheromaCardioembolic StrokeCardiomyopathiesCardiovascular StrokeThromboembolism
Interventions
DIAGNOSTIC_TEST

ISCDX blood test

"The ISCDX test is based on gene expression changes that occur as a result of the ischemic stroke. When the stroke occurs, the immune system in the body reacts and causes changes in gene expression in several types of cells, including white blood cells, related to activation of innate and adaptive immune systems.~The ISCDX test distinguishes between cardioembolic and large artery atherosclerotic origin of stroke using a gene signature. The pattern or signature of up or down regulation for all genes for a patient determines whether the patient's pattern of gene expression is more like the pattern seen in other cardioembolic patients or more like the pattern seen in patients with large artery atherosclerotic cause of stroke."

Trial Locations (1)

43214

RECRUITING

Ohio Health Riveside Methodist Hospital, Columbus

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ischemia Care LLC

INDUSTRY